Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Aug-Sep;21(4):281-6.
doi: 10.1177/1533317506290448.

Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations

Affiliations
Review

Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations

Mario F Mendez et al. Am J Alzheimers Dis Other Demen. 2006 Aug-Sep.

Abstract

Frontal behavioral changes may be the presenting features of single-photon emission tomography (presenilin-1 [PS-1]) mutations, the most common cause of familial Alzheimer's disease (AD). The authors describe a PS-1 (M233L) mutation with the features of frontotemporal dementia (FTD) and review the literature. PS-1 mutations may produce FTD-like phenotypes with the neuropathology of AD. Some PS-1 mutations have additional Pick's bodies, a neuropathological marker of FTD, and a report of a PS-1 (G183V) mutation found Pick's bodies without amyloid plaques. The patient and the literature suggest that PS-1 mutations result in an overlapping continuum of the clinical and neuropathological features of AD and FTD. In PS-1 mutations, the expression of AD or FTD may depend on the degree of loss of function of the PS-1 gene and the resultant tau pathophysiology.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cruts M, Van Broeckhoven C. Presenilin mutations in AD. Hum Mutat. 1998;11:183-190. - PubMed
    1. van Duijn CM, Hendriks L, Farrer LA, et al. A populationbased study of familial Alzheimer disease: linkage to chromosomes 14, 19, and 21. Am J Hum Genet. 1994;55: 714-727. - PMC - PubMed
    1. Lleó A, Berezovska O, Growdon JH, Hyman BT. Clinical, pathological, and biochemical spectrum of Alzheimer's disease associated with PS-1 mutations. Am J Geriatr Psychiatry. 2004;12:146-156. - PubMed
    1. Lippa CF, Swearer JM, Kane KJ, et al. Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann Neurol.2000;48:376-379. - PubMed
    1. Smith MJ, Kwok JB, McLean CA, et al. Variable phenotype of Alzheimer's disease with spastic paraparesis. Ann Neurol. 2001;49:125-129. - PubMed